- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01822704
Whole Body Vibration in Chronic Stroke
April 1, 2013 updated by: Marco Yiu-Chung Pang, The Hong Kong Polytechnic University
Application of Vertical Whole Body Vibration in Stroke Patients: Neuromuscular Effects, and Clinical Efficacy
This study is a randomized controlled trial aimed to assess the efficacy of a 10-week whole body vibration training program on physical functioning, societal participation and quality of life in individuals with chronic stroke.
It is hypothesized that the whole body vibration program will induce significantly more gain in physical functioning, societal participation, and quality of life in chronic stroke patients, compared with the control group.
Study Overview
Status
Unknown
Conditions
Study Type
Interventional
Enrollment (Anticipated)
81
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kowloon
-
Hung Hom, Kowloon, Hong Kong
- Recruiting
- The Hong Kong Polytechnic University
-
Contact:
- Alan Liao, MPT
- Phone Number: 852-2766-4845
- Email: lr-liao@126.com
-
Principal Investigator:
- Marco Y Pang, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- diagnosis of a hemispheric stroke
- chronic stroke (onset of 6 months or more)
- aged 18 years or older
- medically stable
- able to stand for at least 1 minute with hand support
- Abbreviated Mental Test score at 6 or more
- Chedoke McMaster Stroke Assessment leg or foot score less than 7 points
Exclusion Criteria:
- recurrent stroke
- brainstem or cerebellar stroke
- other neurological conditions
- significant musculoskeletal conditions (e.g. amputations)
- vestibular disorders
- peripheral vascular disease
- other serious illnesses
- other contraindications to exercise.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control
This group will undergo three 45-minute exercise sessions per week for 10 weeks.
No whole body vibration will be given.
|
|
|
Experimental: Low intensity vibration
This group will receive three 45-minute whole body vibration training sessions for 10 consecutive weeks.
The vibration will be of low intensity (frequency: 20 Hertz, amplitude: 1mm).
|
|
|
Experimental: High intensity vibration
This group will receive three 45-minute whole body vibration training sessions per week for 10 consecutive weeks.The vibration will be of higher intensity than the low intensity vibration group (frequency: 30 Hertz, amplitude: 1mm).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Isometric knee muscle strength
Time Frame: Week 0
|
Week 0
|
|
Isometric knee muscle strength
Time Frame: week 10
|
week 10
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Eccentric knee muscle strength at a velocity of 60 degrees per second
Time Frame: Week 0
|
Week 0
|
|
Eccentric knee muscle strength at a velocity of 60 degrees per second
Time Frame: week 10
|
week 10
|
|
Concentric knee muscle strength at a velocity of 60 degrees per second
Time Frame: week 0
|
week 0
|
|
Concentric knee muscle strength at a velocity of 60 degrees per second
Time Frame: week 10
|
week 10
|
|
Distance walked in the Six Minute Walk Test
Time Frame: week 0
|
week 0
|
|
Distance walked in the Six Minute Walk Test
Time Frame: week 10
|
week 10
|
|
Average oxygen consumption rate during the Six Minute Walk Test
Time Frame: week 0
|
week 0
|
|
Average oxygen consumption rate during the Six Minute Walk Test
Time Frame: week 10
|
week 10
|
|
Time taken to complete the Timed Up and Go Test
Time Frame: week 0
|
week 0
|
|
Time taken to complete the Timed Up and Go Test
Time Frame: week 10
|
week 10
|
|
Time taken to complete the Five-times-sit-to-stand test
Time Frame: week 0
|
week 0
|
|
Time taken to complete the Five-times-sit-to-stand test
Time Frame: week 10
|
week 10
|
|
Distance reached in the Functional Reach test
Time Frame: Week 0
|
Week 0
|
|
Distance reached in the Functional Reach test
Time Frame: week 10
|
week 10
|
|
Balance score as measured by the Mini-Balance Evaluation Systems Test
Time Frame: week 0
|
week 0
|
|
Balance score as measured by the Mini-Balance Evaluation Systems Test
Time Frame: week 10
|
week 10
|
|
Walking ability as measured by the Functional Ambulation Category
Time Frame: week 0
|
week 0
|
|
Walking ability as measured by the Functional Ambulation Category
Time Frame: week 10
|
week 10
|
|
Balance confidence scores as measured by the Activities-specific Balance Confidence Scale
Time Frame: week 0
|
week 0
|
|
Balance confidence scores as measured by the Activities-specific Balance Confidence Scale
Time Frame: week 10
|
week 10
|
|
Quality of life score as measured by the 12-item Short Form Health Survey
Time Frame: week 0
|
week 0
|
|
Quality of life score as measured by the 12-item Short Form Health Survey
Time Frame: week 10
|
week 10
|
|
Level of activity participation as measured by the Frenchay Activities Index
Time Frame: week 0
|
week 0
|
|
Level of activity participation as measured by the Frenchay Activities Index
Time Frame: Week 10
|
Week 10
|
|
Level of perceived environmental barriers as measured by the Craig Hospital Inventory of Environmental Factors
Time Frame: week 0
|
week 0
|
|
Level of perceived environmental barriers as measured by the Craig Hospital Inventory of Environmental Factors
Time Frame: week 10
|
week 10
|
|
Ankle spasticity score as measured by the Modified Ashworth Scale
Time Frame: week 0
|
week 0
|
|
Ankle spasticity score as measured by the Modified Ashworth Scale
Time Frame: week 10
|
week 10
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Marco YC Pang, PhD, The Hong Kong Polytechnic University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2013
Primary Completion (Anticipated)
November 1, 2014
Study Completion (Anticipated)
May 1, 2015
Study Registration Dates
First Submitted
March 28, 2013
First Submitted That Met QC Criteria
March 28, 2013
First Posted (Estimate)
April 2, 2013
Study Record Updates
Last Update Posted (Estimate)
April 4, 2013
Last Update Submitted That Met QC Criteria
April 1, 2013
Last Verified
April 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSEARS20130209001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
Clinical Trials on Leg exercises
-
Norther Private Collage of NursingNot yet recruitingHemodialysis | Excercise | Functional Capacities
-
Swiss Federal Institute of TechnologyCompletedCardiovascular Deconditioning
-
Riphah International UniversityCompletedLow Back Pain | Hamstring PulledPakistan
-
University of SharjahNot yet recruiting
-
Gurkan KAPIKIRANCompletedPain | Anxiety | SurgeryTurkey
-
Cairo UniversityCompleted
-
University of Health Sciences LahoreActive, not recruitingWaist Circumference | Abdominal Muscles Strength | Abdominal Muscles Endurance | Abdominal Muscles FlexibilityPakistan
-
Riphah International UniversityCompletedWeakness, Muscle | SIJ - Sprain of Sacroiliac Joint | Tightness of Back MusclesPakistan
-
Eunice Kennedy Shriver National Institute of Child...Rockefeller UniversityCompletedHyperbilirubinemia | Glucosephosphate Dehydrogenase Deficiency | Hemolytic Disease of NewbornUnited States
-
University of AlbertaAlberta Innovates Health SolutionsCompleted